The Indian rupee weakened on Monday on the back of strong demand to buy dollars at the daily reference rate and as the ...

Despite Q4 earnings hit by transaction costs, CBIZ expects smoother progress and significant growth in 2025. See why I ...

Quality dividend stocks yielding 7% and more are the best ideas for many investors now. These five are too cheap to ignore ...

TeraWulf's HPC expansion, including a $1B Core42 agreement, suggests significant future revenue growth. Read why I upgrade ...

Analysts are showing growing confidence in European and Chinese tech stocks as they outperform the S&P 500 (SPX). Many ...

The majority of growth stocks are unprofitable, making them risky investments. However, growth companies tend to operate in ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Solid Biosciences (SLDB – Research Report). The company’s ...

CytomX Therapeutics (CTMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: PennantPark Floating Rate Capital Ltd. PFLT: This business development company that seeks to make debt, equity, and loan ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Molson Coors Beverage Company TAP: This beer and malt beverages company has seen the Zacks Consensus Estimate for its ...

Commerce Bancshares (CBSH) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...